Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients.

Kremer L, Mealy M, Jacob A, Nakashima I, Cabre P, Bigi S, Paul F, Jarius S, Aktas O, Elsone L, Mutch K, Levy M, Takai Y, Collongues N, Banwell B, Fujihara K, de Seze J.

Mult Scler. 2014 Jun;20(7):843-7. doi: 10.1177/1352458513507822. Epub 2013 Oct 7.

PMID:
24099751
2.

Epidemiological, clinical and immunological aspects of neuromyelitis optica (NMO).

Asgari N.

Dan Med J. 2013 Oct;60(10):B4730. Review.

PMID:
24083534
3.

The role of anti-aquaporin 4 antibody in the conversion of acute brainstem syndrome to neuromyelitis optica.

Cheng C, Jiang Y, Lu X, Gu F, Kang Z, Dai Y, Lu Z, Hu X.

BMC Neurol. 2016 Oct 21;16(1):203.

4.

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.

Kitley J, Waters P, Woodhall M, Leite MI, Murchison A, George J, Küker W, Chandratre S, Vincent A, Palace J.

JAMA Neurol. 2014 Mar;71(3):276-83. doi: 10.1001/jamaneurol.2013.5857.

PMID:
24425068
5.

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients.

Jarius S, Ruprecht K, Wildemann B, Kuempfel T, Ringelstein M, Geis C, Kleiter I, Kleinschnitz C, Berthele A, Brettschneider J, Hellwig K, Hemmer B, Linker RA, Lauda F, Mayer CA, Tumani H, Melms A, Trebst C, Stangel M, Marziniak M, Hoffmann F, Schippling S, Faiss JH, Neuhaus O, Ettrich B, Zentner C, Guthke K, Hofstadt-van Oy U, Reuss R, Pellkofer H, Ziemann U, Kern P, Wandinger KP, Bergh FT, Boettcher T, Langel S, Liebetrau M, Rommer PS, Niehaus S, Münch C, Winkelmann A, Zettl U UK, Metz I, Veauthier C, Sieb JP, Wilke C, Hartung HP, Aktas O, Paul F.

J Neuroinflammation. 2012 Jan 19;9:14. doi: 10.1186/1742-2094-9-14.

6.

Prominent brainstem symptoms/signs in patients with neuromyelitis optica in a Taiwanese population.

Wang KC, Lee CL, Chen SY, Lin KH, Tsai CP.

J Clin Neurosci. 2011 Sep;18(9):1197-200. doi: 10.1016/j.jocn.2010.12.052. Epub 2011 Jul 18.

PMID:
21764586
7.

[Prognostic value of aquaporin-4 antibody in patients of inflammatory demyelinating diseases in central nervous system].

Yang Y, Wu WP, Huang DH, Wu L.

Zhonghua Yi Xue Za Zhi. 2012 Nov 20;92(43):3032-5. Chinese.

PMID:
23328372
8.

Diagnostic value of aquaporin 4 antibody in assessing idiopathic inflammatory demyelinating central nervous system diseases in Egyptian patients.

Kishk NA, Abokrysha NT, Rashed L, Ahmed N.

J Clin Neurosci. 2015 Apr;22(4):670-5. doi: 10.1016/j.jocn.2014.09.024. Epub 2015 Feb 9.

PMID:
25677878
9.

Early and extensive spinal white matter involvement in neuromyelitis optica.

Hayashida S, Masaki K, Yonekawa T, Suzuki SO, Hiwatashi A, Matsushita T, Watanabe M, Yamasaki R, Suenaga T, Iwaki T, Murai H, Kira JI.

Brain Pathol. 2017 May;27(3):249-265. doi: 10.1111/bpa.12386. Epub 2016 Jun 29.

PMID:
27082714
10.

Aquaporin-4 antibodies, CNS acidosis and neuromyelitis optica: a potential link.

Jarius S, Wildemann B.

Med Hypotheses. 2013 Dec;81(6):1090-5. doi: 10.1016/j.mehy.2013.10.011. Epub 2013 Oct 16.

PMID:
24182872
12.

Modifications of longitudinally extensive transverse myelitis and brainstem lesions in the course of neuromyelitis optica (NMO): a population-based, descriptive study.

Asgari N, Skejoe HP, Lillevang ST, Steenstrup T, Stenager E, Kyvik KO.

BMC Neurol. 2013 Apr 8;13:33. doi: 10.1186/1471-2377-13-33.

13.

Clinical manifestations of neuromyelitis optica in male and female patients.

Yin J, Long Y, Shan F, Fan Y, Wu L, Zhong R, Gao C, Chen X, Gao Q, Yang N.

Neurol Res. 2015 Nov;37(11):967-73. doi: 10.1179/1743132815Y.0000000081. Epub 2015 Jul 27.

PMID:
26213113
14.

[Evolution of Devic's neuromyelitis optica spectrum disorders].

Bernard-Valnet R, Marignier R.

Presse Med. 2015 Apr;44(4 Pt 1):401-10. doi: 10.1016/j.lpm.2014.05.030. Epub 2014 Dec 18. French.

PMID:
25535163
15.

Retinal segmented layers with strong aquaporin-4 expression suffered more injuries in neuromyelitis optica spectrum disorders compared with optic neuritis with aquaporin-4 antibody seronegativity detected by optical coherence tomography.

Peng CX, Li HY, Wang W, Wang JQ, Wang L, Xu QG, Cao SS, Zhou HF, Zhao S, Wei SH.

Br J Ophthalmol. 2017 Aug;101(8):1032-1037. doi: 10.1136/bjophthalmol-2016-309412. Epub 2017 Jan 5.

PMID:
28057643
16.

[Differential diagnosis of neuromyelitis optica spectrum disorders].

Tanaka K, Tanaka M.

Brain Nerve. 2010 Sep;62(9):953-60. Review. Japanese.

PMID:
20844306
17.

Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature.

Jarius S, Wildemann B.

Brain Pathol. 2013 Nov;23(6):661-83. doi: 10.1111/bpa.12084. Review.

PMID:
24118483
18.

Increased occurrence of anti-AQP4 seropositivity and unique HLA Class II associations with neuromyelitis optica (NMO), among Muslim Arabs in Israel.

Brill L, Mandel M, Karussis D, Petrou P, Miller K, Ben-Hur T, Karni A, Paltiel O, Israel S, Vaknin-Dembinsky A.

J Neuroimmunol. 2016 Apr 15;293:65-70. doi: 10.1016/j.jneuroim.2016.02.006. Epub 2016 Feb 15.

PMID:
27049564
19.

Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody.

Kurosawa K, Misu T, Takai Y, Sato DK, Takahashi T, Abe Y, Iwanari H, Ogawa R, Nakashima I, Fujihara K, Hamakubo T, Yasui M, Aoki M.

Acta Neuropathol Commun. 2015 Dec 4;3:82. doi: 10.1186/s40478-015-0259-2.

20.

No association of AQP4 polymorphisms with neuromyelitis optica and multiple sclerosis.

Yang TT, He Y, Xiang YJ, Ao DH, Wang YY, Zhang Q, He XJ, Zhong SS, Wu J, Liu GZ.

Transl Neurosci. 2016 Aug 22;7(1):76-83. doi: 10.1515/tnsci-2016-0012. eCollection 2016.

Supplemental Content

Support Center